[1]. Effect of a novel nasal oxytocin spray with enhanced bioavailability on autism: a randomized trial.
Brain : a journal of neurology [Volume]145 [Issue]2 [Page]490 -499 （2022/）
[DOI] [2]. Extrastriatal dopamine D2/3 receptor binding, functional connectivity, and autism socio-communicational deficits: a PET and fMRI study.
Molecular psychiatry （2022/） [Reviewed] Yes
[DOI] [Repository][3]. Serum levels of glial cell line-derived neurotrophic factor as a biomarker for mood disorders and lithium response.
Psychiatry research [Volume]301 [Page]113967 （2021/）
[DOI] [4]. Oxytocin-induced increase in N,N-dimethylglycine and time course of changes in oxytocin efficacy for autism social core symptoms.
Molecular autism [Volume]12 [Issue]1 [Page]15 （2021/）
[DOI] [5]. Platelet-derived growth factor BB: A potential diagnostic blood biomarker for differentiating bipolar disorder from major depressive disorder.
Journal of psychiatric research [Volume]134 [Page]48 -56 （2021/）
[DOI]